Zenas BioPharma, Inc. Deferred Costs, Noncurrent
Zenas BioPharma, Inc. (ZBIO) had Deferred Costs, Noncurrent of $486.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-08-13
- 2026-06-30: Deferred Costs, Noncurrent $486.00K.
- 2026-03-31: Deferred Costs, Noncurrent $439.00K.
- 2025-12-31: Deferred Costs, Noncurrent $709.00K.
- 2025-09-30: Deferred Costs, Noncurrent $837.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2026-06-30 | $486.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $439.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $709.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $837.00K 10-Q · filed 2025-11-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2023-12-31 | $1.39M 10-K · filed 2025-03-11 |